Analysed SIEMENS HEALTHINEE-UNSP ADR (SMMNY:OTCMKTS) News Sources
Siemens Healthineers AG (SMMNY) Q1 2026 Earnings Call Highlights: Strong Imaging and Precision ...
07-02-2026
yahoo.com
AI in Oncology Research and Long-term Forecasts Report 2026-2040: Siemens Healthineers and GE Healthcare Lead, While NVIDIA, IBM, Tempus, PathAI, and Emerging Specialists Expand Use Cases
10-02-2026
yahoo.com
Has Siemens Healthineers (XTRA:SHL) Fallen Too Far After Recent Share Price Weakness?
11-02-2026
yahoo.com
Siemens Aktiengesellschaft AGM: Record FY2025, Raised Outlook, AI Push and Healthineers Spin-Off Plan
12-02-2026
marketbeat.com
Telemedicine & Digital Health Research Report 2026: A $180 Billion Market by 2031 from $85.5 Billion in 2025 with Teladoc Health, Amwell, Philips, Siemens Healthineers, GE, Medtronic, Oracle Leading
17-02-2026
yahoo.com
Siemens Healthineers Q1: Imaging, Precision Therapy drive growth as China weighs on Diagnostics
20-02-2026
marketbeat.com
What is the current price of SIEMENS HEALTHINEE-UNSP ADR (SMMNY:OTCMKTS)?
The current price of SIEMENS HEALTHINEE-UNSP ADR (SMMNY:OTCMKTS) is $22.8.
SIEMENS HEALTHINEE-UNSP ADR (SMMNY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of SIEMENS HEALTHINEE-UNSP ADR (SMMNY:OTCMKTS) since the previous trading day is $0.01.
SIEMENS HEALTHINEE-UNSP ADR (SMMNY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of SIEMENS HEALTHINEE-UNSP ADR (SMMNY:OTCMKTS) since the previous trading day is 0.0439%.
What is the most recent average sentiment score for SIEMENS HEALTHINEE-UNSP ADR (SMMNY:OTCMKTS)?
The most recent average sentiment score for SIEMENS HEALTHINEE-UNSP ADR (SMMNY:OTCMKTS) is 74 out of 100.
What is the most recent average sentiment for SIEMENS HEALTHINEE-UNSP ADR (SMMNY:OTCMKTS)?
The most recent sentiment for SIEMENS HEALTHINEE-UNSP ADR (SMMNY:OTCMKTS) is .
SEC-8K** Filing Available For SIEMENS HEALTHINEE-UNSP ADR (SMMNY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.